- Home
- PBYI vs INSG Comparison
PBYI vs INSG Comparison
Compare PBYI & INSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- INSG
- Stock Information
- Founded
- PBYI 2010
- INSG 1996
- Country
- PBYI United States
- INSG United States
- Employees
- PBYI N/A
- INSG N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- INSG Telecommunications Equipment
- Sector
- PBYI Health Care
- INSG Telecommunications
- Exchange
- PBYI Nasdaq
- INSG Nasdaq
- Market Cap
- PBYI 138.4M
- INSG 111.5M
- IPO Year
- PBYI N/A
- INSG 2000
- Fundamental
- Price
- PBYI $3.07
- INSG $8.48
- Analyst Decision
- PBYI Strong Buy
- INSG Buy
- Analyst Count
- PBYI 1
- INSG 3
- Target Price
- PBYI $7.00
- INSG $13.00
- AVG Volume (30 Days)
- PBYI 275.3K
- INSG 87.2K
- Earning Date
- PBYI 05-08-2025
- INSG 05-08-2025
- Dividend Yield
- PBYI N/A
- INSG N/A
- EPS Growth
- PBYI 37.78
- INSG N/A
- EPS
- PBYI 0.62
- INSG 0.10
- Revenue
- PBYI $230,468,000.00
- INSG $191,244,000.00
- Revenue This Year
- PBYI N/A
- INSG $2.53
- Revenue Next Year
- PBYI N/A
- INSG $11.55
- P/E Ratio
- PBYI $4.92
- INSG $81.58
- Revenue Growth
- PBYI N/A
- INSG 14.32
- 52 Week Low
- PBYI $2.23
- INSG $3.70
- 52 Week High
- PBYI $5.20
- INSG $20.67
- Technical
- Relative Strength Index (RSI)
- PBYI 51.76
- INSG 53.95
- Support Level
- PBYI $2.88
- INSG $8.00
- Resistance Level
- PBYI $3.14
- INSG $8.60
- Average True Range (ATR)
- PBYI 0.14
- INSG 0.44
- MACD
- PBYI 0.01
- INSG 0.13
- Stochastic Oscillator
- PBYI 64.00
- INSG 81.16
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About INSG Inseego Corp.
Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).